Doctor SKIN Spółka z Ograniczoną Odpowiedzialnością (KRS 0001014670, NIP 7123448351) is a Polish company, headquartered in Lublin, Lubelskie voivodeship. Doctor SKIN operates in: Computer programming activities (PKD 62.01.Z). Industry: IT and software. The company has been listed in the National Court Register since January 20, 2023. Doctor SKIN's most recently reported net revenue was 0 PLN for 2024.
No arrears identified in the analysed sources
No arrears or bankruptcy proceedings identified in the analysed sources.
Business profile - Doctor SKIN
Identity
- Name
- Doctor SKIN Spółka z Ograniczoną Odpowiedzialnością
- Legal form
- Limited Liability Company (LLC)
- Founded
- January 20, 2023
- Registry status as of
- November 21, 2025
- Latest entry
- July 18, 2025
- Founding act
- 19.01.2023
Articles of association history (1)
- January 19, 2023: 19.01.2023
Activities
Other activities
General codes (divisions and groups)
General codes indicate a PKD division or group without a specific subclass.
Address and contact
- Address
- ZWIĄZKOWA, 26, 20-148, LUBLIN, POLSKA
- Voivodeship
- LUBELSKIE
- District
- LUBLIN
- Not disclosed in the registry
- Website
- Not disclosed in the registry
- E-delivery address
- Not disclosed in the registry
Risk and payment profile - Doctor SKIN
Credibility rating
54.4 / 100
Average credibility
Insolvency risk
Very low
Low threat
Closure risk
15
/ 100
Risk comparison - scale 0 (safe) → 100 (critical)
Organisational stability signals
No instability signals - ownership, management, PKD codes and company name remain relatively stable.
Shareholder changes
0
0/3 yrs
Board changes
0
0/3 yrs
PKD changes
0
0/3 yrs
Name changes
0
0/3 yrs
Data from 3 years of registry activity.
Credibility history
Payment reliability score from 2023–2024
Current: D (54/100)
Trend: stable (+0.3 pts/year)
Słaba wiarygodność płatnicza – wskaźniki finansowe sugerują podwyższone ryzyko opóźnień lub niewykonania zobowiązań.
Trade credit limit history
Standard limit from 2023–2024
Current: 0 PLN
Safe: 0 PLN
Difference between risk models
Closure - probability of ceasing operations (operational continuity). Insolvency - probability of formal bankruptcy / restructuring. The models use different data - results can diverge significantly when balance-sheet data is incomplete.
Operational status - Doctor SKIN
Founded
January 20, 2023
3 years in operation
Legal form
Limited Liability Company (LLC)
Registry: RejP
Headquarters
LUBLIN
LUBELSKIE
Primary PKD
62.01.Z
Computer programming activities
Share capital
5.0 K PLN
100 shares total
Shareholders
1
shareholder
Board
1 person
Filed years
2 years
2023–2024
Registry entries
8
latest: July 18, 2025
Revenue
0 PLN
2024
Net profit
0 PLN
2024
Assets
5.0 K PLN
2024
Equity
5.0 K PLN
2024
Valuation
4.3 K PLN
Low confidence
Low confidence
Board and connected people - Doctor SKIN
People holding roles at Doctor SKIN according to the Polish National Court Register. Follow a name for that person's full profile and their other companies.
- Maciej ŻmurekPresident of the board, Sole shareholder
Directories and rankings for this location
Public procurement
Trademarks
Reviews
Rate business credibility - Doctor SKIN.
No ratings
Related articles
News
Ailleron in 2026: record PLN 579.7 m revenue, the Tailwind deal for Software Mind collapses, LiveBank moves into Canada
Kraków-based Ailleron S.A. (KRS 0000385276) closed 2025 with record revenue of PLN 579.7m (+4% YoY) and net profit of PLN 25.7m, with 77% of sales generated by exports. In April 2026 negotiations with Tailwind Capital Partners over a 100% sale of Software Mind broke down. New CEO Tomasz Król is betting on LiveBank expansion in North and South America (a contract with one of Canada's five largest banks).
News
CI Games 2025: back in the black with PLN 5.2m of profit – heading into a Lords of the Fallen II launch year with a PLN 160m budget
Warsaw-based CI Games SE (KRS 0000282076) closed 2025 with revenue of PLN 73.8m, EBITDA of PLN 32.5m (a 44.1% margin) and net profit of PLN 5.2m – its first positive bottom line in two years. Lords of the Fallen (2023) passed 2.5m units sold. The sequel, developed by Hexworks in Barcelona, is in intensive testing, with release planned for 2026 on a budget of about PLN 160m, the largest in the company's history. In March 2026 the company raised roughly PLN 70m gross through an accelerated book-build of Series M shares.
